Philip Morris Products S.A.’s IQOS Tobacco Heating System can now be marketed as a tobacco harm reduction product.

This week, House Democrats brought to the floor H.R. 1425, with no bipartisan committee input and no amendments allowed.

One of the many programs whose problems seem to have gotten lost during the response to the COVID-19 pandemic is the 340B drug safety-net program.

On June 16, The Wall Street Journal published an opinion by Vice President Michael Pence, "There Isn’t a Coronavirus 'Second Wave.'"  The numbers show he is right.

HB 673 will reduce regulatory barriers to help the state recover and reopen from the coronavirus pandemic.

In May, President Trump issued Executive Order (EO) 13924 to combat the economic consequences of the coronavirus.

The White House last night released its plan for solving the surprise billing issue, which has been a hot debate in Congress since late 2019. 

Medicare Part D Demonstration Model Shows Promise to Lower Insulin Costs for Seniors

There have been urgent calls to require pharmaceutical and medical device manufacturers to create all their products in the U.S. – but is that wise?